TRIATET

Welcome to the Brand page for “TRIATET”, which is offered here for Antiretroviral drug for the treatment of hiv-1 infection in adults;.

Its status is currently believed to be active. Its class is unavailable. “TRIATET” is believed to be currently owned by “Teva Pharmaceuticals USA, Inc.”


Owner:
TEVA PHARMACEUTICALS USA, INC.
Owner Details
Description:
Antiretroviral drug for the treatment of HIV-1 infection in adults;
Categories: ANTIRETROVIRAL DRUG TREATMENT